arrow
E

Emma Evertsson

AstraZeneca
H指数:10
被引数:536
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The changing landscape of medicinal chemistry optimization

药物化学优化的变化格局

2025-07-070
PRE
Vinylpyridine as a Tunable Covalent Warhead Targeting C797 in EGFR
2024-04-050
PRE
Augmenting DMTA using predictive AI modelling at AstraZeneca

在阿斯利康使用预测AI模型增强DMTA

2024-04-019
OAAI
Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function
2020-04-0110
OAAI
Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligands
2019-11-2221
OAAI
An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of Activation Inhibitors
2019-08-134
PREAI
Experimental and Quantum Chemical Evaluations of Pyridine Oxidation Under Drug Development Stress Test Conditions
2015-12-012
PREAI
Predicting the relative binding affinity of mineralocorticoid receptor antagonists by density functional methods
2015-11-166
PREAI
A Qualitative Method for Prediction of Amine Oxidation in Methanol and Water
2015-04-015
PREAI
Discovery and Characterization of MAPK-activated Protein Kinase-2 Prevention of Activation Inhibitors
2014-10-098
PREAI
Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein-Protein Interaction
2014-02-2140
OA
Synthesis and Functionalization of Cyclic Sulfonimidamides: A Novel Chiral Heterocyclic Carboxylic Acid Bioisostere
2012-06-0547
OAAI